Manufacturer record
Samay Pharma India Pvt. Ltd. Plot No. 34-35: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Samay Pharma India Pvt. Ltd. Plot No. 34-35 (Himachal Pradesh) were declared Not of Standard Quality between April 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Samay Pharma India Pvt. Ltd. Plot No. 34-35 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ondansetron Orally Disintegration Tablets IP | ST-34645Mfg 2024-10 · Exp 2026-09 | Disintegration TestDisintegration | Lucknow LabState lab | Jul 2026 |
| R Zara-DSR Capsules | SC-05856Mfg 2025-10 · Exp 2027-09 | SPURIOUS 1.The sample fails in the test for Identification & also the Assay contents of Rabeprazole Sodium IP & Domperidone IP are found NIL. 2.The sample is also found Misbranded as Sunset Yellow in the label needs to be mentioned Sunset Yellow FCF.Assay | MDTL KathuaState lab | Apr 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.